- AI
- Molecular Imaging
- CT
- X-Ray
- Ultrasound
- MRI
- Facility Management
- Mammography
Thyroid Imaging Reporting and Data System Reduces Biopsies
Using the American College of Radiology Thyroid Imaging Reporting and Data System criteria results in fewer biopsies and more accurate recommendations.
Criteria from the American College of Radiology (ACR) Thyroid Imaging Reporting and Data System (TI-RADS) offers a meaningful reduction in the number of thyroid nodules recommended for biopsy, according to a study published in the journal Radiology.
Researchers from several states performed a retrospective study to compare the biopsy rate and diagnostic accuracy before and after applying ACR TI-RADS criteria for thyroid nodule evaluation. Eight radiologists with three to 32 years of experience in thyroid ultrasonography were asked to review the ultrasound features of 100 thyroid nodules that were cytologically proven and/or pathologically proven. Nodules evaluated in five US categories and biopsy recommendations were provided based on the radiologists’ practice patterns without knowledge of ACR TI-RADS criteria. Three other expert radiologists were reference standard readers for the imaging findings. ACR TI-RADS criteria were retrospectively applied to the features assigned by the eight radiologists to produce biopsy recommendations. Comparison was made for biopsy rate, sensitivity, specificity, and accuracy.
The results showed 15 of the 100 nodules (15 percent) were malignant. The mean number of nodules recommended for biopsy by the eight radiologists was 80 ± 16 (standard deviation) based on their own practice patterns and 57 ± 11 with retrospective application of ACR TI-RADS criteria.
Without ACR TI-RADS criteria:
Sensitivity 95 percent
Specificity 20 percent
Accuracy 28 percent
With ACR TI-RADS criteria:
Sensitivity 92 percent
Specificity 44 percent
Accuracy 52 percent
Expert consensus:
Sensitivity 87 percent
Specificity 51 percent
Accuracy 56 percent
The researchers noted that although fewer malignancies were recommended for biopsy with ACR TI-RADS criteria, the majority met the criteria for follow-up US. Only three of 120 (2.5 percent) malignancy encounters required no follow-up or biopsy. Expert consensus recommended biopsy in 55 of 100 nodules with ACR TI-RADS criteria.
Not only did the ACR TI-RADS criteria offer a meaningful reduction in the number of thyroid nodules recommended for biopsy, the researchers wrote, they significantly improve the accuracy of recommendations for nodule management.
The Reading Room: Racial and Ethnic Minorities, Cancer Screenings, and COVID-19
November 3rd 2020In this podcast episode, Dr. Shalom Kalnicki, from Montefiore and Albert Einstein College of Medicine, discusses the disparities minority patients face with cancer screenings and what can be done to increase access during the pandemic.
New Study Examines Agreement Between Radiologists and Referring Clinicians on Follow-Up Imaging
November 18th 2024Agreement on follow-up imaging was 41 percent more likely with recommendations by thoracic radiologists and 36 percent less likely on recommendations for follow-up nuclear imaging, according to new research.
Ultrasound Device Garners FDA De Novo Nod for Kidney Stone Clearance
November 14th 2024Emerging research demonstrated that the Stone Clear device, which facilitates post-lithotripsy clearance of kidney stone fragments, led to a 70 percent lower risk of relapse in comparison to observation in a control group.
